1. Targeting Glycogen Synthase Kinase 3 Beta Regulates CD47 Expression After Myocardial Infarction in Rats via the NF-κB Signaling Pathway
    Li-Na Xu et al, 2021, Frontiers in Pharmacology CrossRef
  2. Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47
    Zuzana Strizova et al, 2020, Scientific Reports CrossRef
  3. Application of CD47 Inhibitor in Tumor Therapy
    嘉欣 李, 2021, Pharmacy Information CrossRef
  4. Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
    Ross King et al, 2021, World Journal of Gastrointestinal Oncology CrossRef

  5. Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies


    Quansheng Lu et al, 2020, OncoTargets and Therapy CrossRef
  6. Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo
    Zu-Chian Chiang et al, 2022, Frontiers in Oncology CrossRef
  7. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
    Ding-Kang Wang et al, 2021, Frontiers in Immunology CrossRef
  8. Knockdown of LMNB1 Inhibits the Proliferation of Lung Adenocarcinoma Cells by Inducing DNA Damage and Cell Senescence
    Jiangbo Li et al, 2022, Frontiers in Oncology CrossRef